Clinical features and outcomes of extramedullary myeloid sarcoma in the United States: analysis using a national data set

nork Goyal, G, Bartley, A C, Patnaik, M M, Litzow, M R, Al-Kali, A, Go, R S
Argitaratua izan da Blood Cancer J (2017)

IPSS-independent prognostic value of plasma CXCL10, IL-7 and IL-6 levels in myelodysplastic syndromes

nork Pardanani, A, Finke, C, Lasho, T L, Al-Kali, A, Begna, K H, Hanson, C A, Tefferi, A
Argitaratua 2012

Monosomal karyotype in Philadelphia chromosome-negative acute lymphoblastic leukemia

nork Kenderian, S S, Al-Kali, A, Gangat, N, Letendre, L, Hogan, W J, Litzow, M R, Patnaik, M M
Argitaratua 2013

Imetelstat therapy in refractory anemia with ring sideroblasts with or without thrombocytosis

nork Tefferi, A, Al-Kali, A, Begna, K H, Patnaik, M M, Lasho, T L, Rizo, A, Wan, Y, Hanson, C A
Argitaratua izan da Blood Cancer J (2016)

A vicious loop of fatty acid-binding protein 4 and DNA methyltransferase 1 promotes acute myeloid leukemia and acts as a therapeutic target

nork Yan, F, Shen, N, Pang, JX, Zhao, N, Zhang, YW, Bode, AM, Al-Kali, A, Litzow, MR, Li, B, Liu, SJ
Argitaratua izan da Leukemia (2017)

Fatty Acid Binding Protein FABP4 Mechanistically Links Obesity with Aggressive AML by Enhancing Aberrant DNA Methylation in AML Cells

nork Yan, F, Shen, N, Pang, JX, Zhang, YW, Rao, EY, Bode, AM, Al-Kali, A, Zhang, DE, Litzow, MR, Li, B, Liu, SJ
Argitaratua izan da Leukemia (2016)

Survival trends in primary myelodysplastic syndromes: a comparative analysis of 1000 patients by year of diagnosis and treatment

nork Gangat, N, Patnaik, M M, Begna, K, Al-Kali, A, Litzow, M R, Ketterling, R P, Hanson, C A, Pardanani, A D, Tefferi, A
Argitaratua izan da Blood Cancer J (2016)

Safety and efficacy of CYT387, a JAK1 and JAK2 inhibitor, in myelofibrosis

nork Pardanani, A, Laborde, R R, Lasho, T L, Finke, C, Begna, K, Al-Kali, A, Hogan, W J, Litzow, M R, Leontovich, A, Kowalski, M, Tefferi, A
Argitaratua 2013

Blinatumomab-induced lineage switch of B-ALL with t(4:11)(q21;q23) KMT2A/AFF1 into an aggressive AML: pre- and post-switch phenotypic, cytogenetic and molecular analysis

nork Haddox, C L, Mangaonkar, A A, Chen, D, Shi, M, He, R, Oliveira, J L, Litzow, M R, Al-Kali, A, Hogan, W J, Elliott, M A
Argitaratua izan da Blood Cancer J (2017)

Genetic determinants of response and survival in momelotinib-treated patients with myelofibrosis

nork Pardanani, A, Abdelrahman, R A, Finke, C, Lasho, T T, Begna, K H, Al-Kali, A, Hogan, W J, Litzow, M R, Hanson, C A, Ketterling, R P, Tefferi, A
Argitaratua izan da Leukemia (2015)

Prognostic relevance of lymphocytopenia, monocytopenia and lymphocyte-to-monocyte ratio in primary myelodysplastic syndromes: a single center experience in 889 patients

nork Saeed, L, Patnaik, M M, Begna, K H, Al-Kali, A, Litzow, M R, Hanson, C A, Ketterling, R P, Porrata, L F, Pardanani, A, Gangat, N, Tefferi, A
Argitaratua izan da Blood Cancer J (2017)